Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stuttgart - Delayed Quote EUR

ABIVAX Société Anonyme (2X10.SG)

Compare
7.05
-0.10
(-1.40%)
At close: February 28 at 4:25:36 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cost of Revenue
--
--
50,764
45,517
33,783
Gross Profit
--
--
-50,764
-45,517
-33,783
Operating Expense
127,376
127,376
51,205
41,398
4,226
Operating Income
-127,376
-127,376
-51,205
-41,398
-38,009
Net Non Operating Interest Income Expense
-12,708
-12,708
-6,717
-3,476
-2,318
Other Income Expense
-7,654
-7,654
-2,820
2,425
200
Pretax Income
-147,740
-147,740
-60,740
-42,452
-40,127
Tax Provision
--
--
--
--
-2,575
Net Income Common Stockholders
-147,740
-147,740
-60,740
-42,452
-37,551
Diluted NI Available to Com Stockholders
-147,740
-147,740
-60,740
-42,452
-37,551
Basic EPS
-3.43
-3.43
-3.18
-2.75
-2.62
Diluted EPS
-3.43
-3.43
-3.18
-2.75
-2.62
Basic Average Shares
43,066.01
43,066.01
19,092.44
15,455.99
14,332.44
Diluted Average Shares
43,066.01
43,066.01
19,092.44
15,455.99
14,332.44
Total Operating Income as Reported
-127,376
-127,376
-64,836
-41,400
-38,008
Rent Expense Supplemental
482
--
1,048
548
504
Total Expenses
127,376
127,376
51,205
41,398
38,009
Net Income from Continuing & Discontinued Operation
-147,740
-147,740
-60,740
-42,452
-37,551
Normalized Income
-136,888
-136,888
-56,474
-44,877
-37,738.17
Interest Income
2,773
2,773
--
--
--
Interest Expense
13,826
13,826
6,940
3,558
2,062
Net Interest Income
-12,708
-12,708
-6,717
-3,476
-2,318
EBIT
-133,914
-133,914
-53,800
-38,894
-38,065
EBITDA
-133,207
-133,207
-53,315
-38,592
-37,999
Reconciled Cost of Revenue
--
--
50,526
45,517
33,783
Reconciled Depreciation
707
707
485
302
66
Net Income from Continuing Operation Net Minority Interest
-147,740
-147,740
-60,740
-42,452
-37,551
Total Unusual Items Excluding Goodwill
-10,852
-10,852
-4,266
2,425
200
Total Unusual Items
-10,852
-10,852
-4,266
2,425
200
Normalized EBITDA
-122,355
-122,355
-49,049
-41,017
-38,199
Tax Rate for Calcs
--
--
--
--
0
Tax Effect of Unusual Items
--
--
--
--
12.83
12/31/2020 - 11/7/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

25I.F ImmuPharma plc
0.0265
-37.65%
 
SANNz.XC
 
0EVI.IL Innate Pharma S.A.
2.1375
-3.93%
 
VTRO
 
KAPA Kairos Pharma, Ltd.
1.1900
-1.65%
 
AFMD Affimed N.V.
1.0300
-0.96%
 
MBX MBX Biosciences, Inc.
9.60
-2.24%
 
ZBIO Zenas BioPharma, Inc.
7.01
+6.05%
 
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
 
CSBR Champions Oncology, Inc.
10.28
+0.59%